Sham LaserCap vs. LaserCap SD vs. LaserCap HD+

Launched by UNIVERSITY OF ARIZONA · May 4, 2022

Keywords

ClinConnect Summary

This clinical trial is investigating the effectiveness of different types of LaserCap devices for treating androgenetic alopecia (AGA), a common form of hair loss that affects many men and women as they age. The study will compare a sham device (which does not emit laser light) to two active devices: one with low energy (LaserCap SD) and another with high energy (LaserCap HD+). The goal is to see if using a higher energy level leads to better hair growth results.

To participate in this trial, individuals must be 25 years or older and have AGA. Eligible men should have a specific level of hair loss, while women should have certain patterns of thinning hair. Participants should not have used any other hair loss treatments for at least six months before joining the trial. Those who take part can expect to wear the LaserCap devices at home and help researchers learn more about how effective these treatments are for boosting hair density. This trial is currently recruiting participants, and everyone is welcome to apply, regardless of gender.

Gender

ALL

Eligibility criteria

• Inclusion criteria:
• • 25 years and older
• • Men and women with AGA, untreated or with 6-month washout of previous treatments
• • Men: Norwood stage IIa - V
• • Women: Ludwig I-1 - II-2, or frontal pattern
• • All patients: Fitzpatrick skin types I to IV
• Exclusion criteria:
• • Men: Norwood stage Va, VI, VII
• • Women: Ludwig stage III, advanced
• • All patients: Fitzpatrick skin types V, VI
• • Current use or within the past six month of other treatment for AGA, including topical and oral minoxidil, topical and oral finasteride and dutasteride
• • Age 0-25 years